Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
604 GBX | -0.33% | +0.04% | -4.95% |
Sales 2022 | -13.58M -16.98M | Sales 2023 | 10.47M 13.09M | Capitalization | 253M 317M |
---|---|---|---|---|---|
Net income 2022 | -22M -27.51M | Net income 2023 | 6M 7.5M | EV / Sales 2022 | -22.5 x |
Net Debt 2022 | 39.98M 49.98M | Net Debt 2023 | 32.47M 40.6M | EV / Sales 2023 | 27.3 x |
P/E ratio 2022 |
-11.9
x | P/E ratio 2023 |
38.4
x | Employees | - |
Yield 2022 |
4.83% | Yield 2023 |
4.38% | Free-Float | 90.86% |
Latest transcript on International Biotechnology Trust plc
1 day | -0.33% | ||
1 week | +0.04% | ||
Current month | -6.98% | ||
1 month | -5.83% | ||
3 months | -7.12% | ||
6 months | +7.82% | ||
Current year | -4.95% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Investment Officer | 47 | - | |
Jonathan Mott
CMP | Compliance Officer | - | - |
Lucy Duarte
IRC | Investor Relations Contact | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 20-05-18 | |
Gillian Elcock
BRD | Director/Board Member | 51 | 23-01-31 |
Director/Board Member | 59 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 610.2 | +0.70% | 10 |
24-04-25 | 606 | -2.57% | 42,457 |
24-04-24 | 622 | -0.80% | 49,003 |
24-04-23 | 627 | +1.46% | 44,486 |
24-04-22 | 618 | +1.31% | 66,458 |
Delayed Quote London S.E., April 26, 2024 at 03:03 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.95% | 286M | |
+4.03% | 14.16B | |
+2.27% | 6.08B | |
+12.30% | 4.27B | |
+10.25% | 4.29B | |
-8.13% | 4B | |
+2.77% | 3.47B | |
+8.89% | 3.2B | |
+6.78% | 2.99B | |
-2.91% | 2.74B |
- Stock Market
- Equities
- IBT Stock